PharmaResearch Co Ltd
KOSDAQ:214450
Wall Street
Price Targets
Price Targets Summary
PharmaResearch Co Ltd
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 346 800 KRW with a low forecast of 292 900 KRW and a high forecast of 409 500 KRW.
Operating Income
Forecast
Operating Income Estimate
PharmaResearch Co Ltd
For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 31%. The projected CAGR for the next 3 years is 34%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PharmaResearch Co Ltd's stock price target?
Price Target
346 800
KRW
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 346 800 KRW with a low forecast of 292 900 KRW and a high forecast of 409 500 KRW.
What is PharmaResearch Co Ltd's Revenue forecast?
Projected CAGR
25%
For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 29%. The projected CAGR for the next 3 years is 25%.
What is PharmaResearch Co Ltd's Operating Income forecast?
Projected CAGR
34%
For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 31%. The projected CAGR for the next 3 years is 34%.
What is PharmaResearch Co Ltd's Net Income forecast?
Projected CAGR
29%
For the last 8 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 27%. The projected CAGR for the next 3 years is 29%.